Education
About Us
Working with TipRanks
Follow Us
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 235.13M | $ 175.51M | $ 134.03M | $ 45.60M | $ 50.12M |
| Gross Profit | $ 206.88M | $ 161.37M | $ 128.37M | $ 44.51M | $ 50.12M |
| Operating Income | $ -4.69M | $ -91.69M | $ -111.47M | $ -180.74M | $ -104.29M |
| EBITDA | $ 31.73M | $ -63.05M | $ -103.65M | $ -177.44M | $ -102.92M |
| Net Income | $ 5.75M | $ -78.02M | $ -108.18M | $ -180.97M | $ -102.68M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 358.48M | $ 350.49M | $ 389.39M | $ 466.08M | $ 398.33M |
| Total Assets | $ 550.64M | $ 548.06M | $ 470.86M | $ 543.37M | $ 463.66M |
| Total Debt | $ 79.37M | $ 97.61M | $ 8.09M | $ 8.74M | $ 8.41M |
| Net Debt | $ -4.06M | $ 48.73M | $ -86.08M | $ -223.16M | $ -263.94M |
| Total Liabilities | $ 173.17M | $ 170.11M | $ 65.42M | $ 64.28M | $ 55.91M |
| Stockholders' Equity | $ 377.48M | $ 377.95M | $ 405.44M | $ 479.09M | $ 407.75M |
| Cash Flow | |||||
| Free Cash Flow | $ 44.11M | $ -34.18M | $ -79.82M | $ -159.19M | $ -77.20M |
| Operating Cash Flow | $ 44.39M | $ -33.46M | $ -79.53M | $ -157.69M | $ -69.86M |
| Investing Cash Flow | $ 39.26M | $ -6.71M | $ -60.63M | $ -103.87M | $ -158.19M |
| Financing Cash Flow | $ -49.09M | $ -5.13M | $ 2.43M | $ 221.11M | $ 194.38M |